Three different B-cell depletion (anti-CD20 monoclonal antibodies) treatments for severe resistant systemic lupus erythematosus

Abstract

Get full access to this article

View all access options for this article.

References

Tahir H. , Rohrer J. , Bhatia A. , Wegener WA , Isenberg DA Humanized anti-CD20 monoclonal antibody in the treatment of severe resistant systemic lupus erythematosus in a patient with antibodies against rituximab . Rheumatology 2005; 44: 561-562.

Stein R. , Qu Z. , Chen S. , et al. Characterization of a new humanized anti-CD20 monoclonal antibody, IMMU-106, and its use in combination with the humanized anti-CD22 antibody, epratuzumab, for the therapy of non-Hodgkin’s lymphoma. Clin Cancer Res 2004; 10: 2868-2878.

Mojcik AF , Klippel JH End-stage renal disease and systemic lupus erythematosus. Am J Med 1996; 101: 100-107.